603739 蔚蓝生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.9983.9663.6354.8144.299
总资产报酬率 ROA (%)0.5842.3192.0832.8762.910
投入资产回报率 ROIC (%)0.7142.8622.5823.4813.455

边际利润分析
销售毛利率 (%)44.22944.79645.04646.22743.231
营业利润率 (%)9.3419.3409.39010.2518.847
息税前利润/营业总收入 (%)10.74310.44210.91911.4009.239
净利润/营业总收入 (%)7.3767.1346.9798.5797.343

收益指标分析
经营活动净收益/利润总额(%)80.17168.63880.00085.72486.406
价值变动净收益/利润总额(%)10.28225.3135.73412.7653.406
营业外收支净额/利润总额(%)0.004-3.141-0.470-0.331-0.701

偿债能力分析
流动比率 (X)1.1901.1701.0371.0331.503
速动比率 (X)0.9680.9460.8530.8441.234
资产负债率 (%)37.38537.14037.26939.83732.764
带息债务/全部投入资本 (%)26.40325.60724.84027.95422.397
股东权益/带息债务 (%)269.831280.744291.569249.206336.089
股东权益/负债合计 (%)156.497157.893156.413141.336194.654
利息保障倍数 (X)7.6617.5326.9429.63720.368

营运能力分析
应收账款周转天数 (天)99.92996.11191.74293.28484.607
存货周转天数 (天)106.83899.12897.800105.83090.137